3D Cell Culture Companies

The 3D cell culture market is projected to reach USD 2.26 billion by 2030 from USD 1.18 billion in 2024, at a CAGR of 11.7% during the forecast period. The growth of this market is mainly driven by the increasing adoption of 3D cell culture over 2D cell culture and the rising demand for personalized medicine across the globe. Furthermore, the emergence of microfluidics-based 3D cell culture is likely to boost market growth in the coming years.

The 3D cell culture market is consolidated. The prominent players operating in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Tecan Trading AG (Switzerland), Avantor, Inc. (US), and REPROCELL Inc. (Japan), among others. The key players of this market are mostly focusing on collaborations, acquisitions, partnerships, agreements, expansion, and advancements in 3D cell culture technology.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific Inc. remains a key player in the 3D cell culture market in 2024, supported by its comprehensive and diversified product portfolio, broad geographic presence, and balanced focus on organic and inorganic growth strategies. In 2024, the company expanded its portfolio by launching advanced 3D cell culture solutions to enhance cancer and stem cell research applications. Thermo Fisher continues to prioritize innovation through significant investments in research and development, ensuring the delivery of cutting-edge technologies that align with the evolving demands of the scientific community. The company’s robust global distribution network further strengthens product accessibility and customer engagement, enabling the company to deliver reliable and scalable 3D cell culture solutions. This integrated strategic approach reinforces Thermo Fisher’s leadership in the 3D cell culture landscape.

Merck KGaA (Germany)

Merck KGaA stands out as a leading player in the 3D cell culture market in 2024, demonstrating a strong commitment to research and development, dedicating significant resources to innovation to advance 3D cell culture applications across research and biopharmaceutical development. Merck’s extensive global distribution network further strengthens accessibility and customer support, enabling the delivery of reliable and high-quality 3D cell culture solutions. This multifaceted approach firmly positions Merck as a key provider in the 3D cell culture landscape. With its strong R&D capabilities and product portfolio, the company is expected to maintain its leading position in the market.

Market Ranking

The 3D cell culture market is characterized by strong competition, with the leading players capturing approximately 42–46% of the total market share. Thermo Fisher Scientific Inc. (US) holds a significant position, supported by its broad portfolio of advanced 3D cell culture solutions and global operational presence. The company’s strength lies in its ability to deliver reliable, scalable, and innovative technologies catering to diverse applications, including cancer research, drug discovery, and regenerative medicine. Other notable competitors, such as Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Tecan Trading AG (Switzerland), and Avantor, Inc. (US), have also secured considerable portions of the market through sustained R&D investments focused on developing high-performance tools that enhance efficiency, reproducibility, and precision in 3D cell culture. Rapidly growing opportunities in the Asia Pacific and Latin American regions are expected to create avenues for these companies to expand their presence, leveraging trends such as increased adoption of 3D models in personalized medicine, toxicology testing, and tissue engineering. Regional and emerging players account for the remaining 54–58% of the market, resulting in notable consolidation within the sector.

Related Reports:

3D Cell Culture Market 3D Cell Culture Market by Product (Scaffolds [Hydrogels, Solid Scaffolds], Scaffold-free [Low Attachment Plates, Microfluidics, Bioprinted]), Application (Cancer, Stem Cell Research, Tissue Engineering), Trends, End User, Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com